Literature DB >> 17954291

Neointimal hyperplasia in early arteriovenous fistula failure.

Prabir Roy-Chaudhury1, Lois Arend, Jianhua Zhang, Mahesh Krishnamoorthy, Yang Wang, Rupak Banerjee, Antoine Samaha, Rino Munda.   

Abstract

BACKGROUND: Hemodialysis vascular access dysfunction currently is a huge clinical problem. Although arteriovenous fistulas (AVFs) are the preferred form of permanent dialysis access, they continue to have significant problems with early AVF failure. Although inadequate dilatation of the venous segment was believed to have a role in early AVF failure, the exact pathogenesis of early AVF failure is unknown despite the magnitude of the clinical problem. STUDY
DESIGN: Case series. SETTING & PARTICIPANTS: Hemodialysis patients. OUTCOMES & MEASUREMENTS: Stenotic venous segments from 4 patients with early AVF failure were subjected to a detailed histological, morphometric, and immunohistochemical analysis.
RESULTS: All 4 patients had significant luminal stenosis, primarily as a result of eccentric neointimal hyperplasia. This was confirmed through morphometric analysis, which documented intima-media area and thickness ratios that were greater than unity. Cellular phenotyping studies showed that the majority of cells within the region of neointimal hyperplasia were myofibroblasts, with smaller numbers of contractile smooth muscle cells. LIMITATIONS: We described only a limited number of specimens.
CONCLUSIONS: We show for the first time that aggressive neointimal hyperplasia is present in venous segment specimens from patients with early AVF failure. Future therapies to address this problem will need to target this pathogenetic pathway.

Entities:  

Mesh:

Year:  2007        PMID: 17954291     DOI: 10.1053/j.ajkd.2007.07.019

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  82 in total

Review 1.  Novel paradigms for dialysis vascular access: upstream hemodynamics and vascular remodeling in dialysis access stenosis.

Authors:  Andrea Remuzzi; Bogdan Ene-Iordache
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

Review 2.  Novel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway?

Authors:  Timmy Lee
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

3.  Association of factor V gene polymorphism with arteriovenous graft failure.

Authors:  Michael Allon; Li Zhang; Ivan D Maya; Molly S Bray; Jose R Fernandez
Journal:  Am J Kidney Dis       Date:  2012-01-24       Impact factor: 8.860

4.  Effectiveness of beraprost sodium in maintaining vascular access patency in patients on hemodialysis.

Authors:  Miyeon Kim; Ji Ung Kim; So Mi Kim; HyunWoo Kim
Journal:  Int Urol Nephrol       Date:  2017-04-13       Impact factor: 2.370

Review 5.  Combined functional and anatomical diagnostic endpoints for assessing arteriovenous fistula dysfunction.

Authors:  Ehsan Rajabi-Jaghargh; Rupak K Banerjee
Journal:  World J Nephrol       Date:  2015-02-06

Review 6.  "Venopathy" at work: recasting neointimal hyperplasia in a new light.

Authors:  Alexander S Yevzlin; Micah R Chan; Yolanda T Becker; Prabir Roy-Chaudhury; Timmy Lee; Bryan N Becker
Journal:  Transl Res       Date:  2010-08-13       Impact factor: 7.012

7.  Novel paradigms for dialysis vascular access: Introduction.

Authors:  Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2013-12       Impact factor: 8.237

8.  Recombinant Human Elastase Treatment of Cephalic Veins.

Authors:  Marco D Wong; Karen Bingham; Emma Moss; J Donald Warn; Igor Smirnov; Kimberly S Bland; Barry Starcher; F Nicholas Franano; Steven K Burke
Journal:  Cardiovasc Pharm Open Access       Date:  2016-04-05

9.  Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodeling.

Authors:  Christine R Mauro; Kui Ding; Hui Xue; Ming Tao; Alban Longchamp; Michael Belkin; Bruce S Kristal; C Keith Ozaki
Journal:  J Vasc Surg       Date:  2014-09-26       Impact factor: 4.268

Review 10.  Challenges and novel therapies for vascular access in haemodialysis.

Authors:  Jeffrey H Lawson; Laura E Niklason; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2020-08-24       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.